Urologists: be aware of significant risks to stopping anticoagulants in patients with drug-eluting coronary stents.
Jones
J Stephen
JS
The Cleveland Clinic, Glickman Urological Institute, Cleveland, OH, USA. joness7@ccf.org
D000925:Anticoagulants / Q000008:administration & dosage*; D001706:Biopsy / Q000009:adverse effects; D016503:Drug Delivery Systems; D006801:Humans; D008297:Male; D011469:Prostatic Diseases / Q000473:pathology*; D012307:Risk Factors; D015607:Stents; D014572:Urology
D000925:Anticoagulants